BMD 60- bacitracin methylene disalicylate granule

BMD by

Drug Labeling and Warnings

BMD by is a Animal medication manufactured, distributed, or labeled by Zoetis Inc., Zoetis LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Bacitracin Methylene Disalicylate
Type A Medicated Article
Antibacterial

For supplementing rations of swine, chickens, turkeys, pheasants, quail and feedlot beef cattle

Active drug ingredient

Each pound contains feed grade bacitracin methylene disalicylate equivalent to 60 grams bacitracin (Master Standard).

Composition

A dried precipitated fermentation product obtained by culturing B. licheniformis Tracy on media adapted for microbiological production of bacitracin; calcium carbonate.

PURPOSE

For manufacturing medicated poultry and livestock feeds only

Mixing directions

Prepare an intermediate premix containing 5 grams per pound by mixing 1.0 lb of BMD 60 with 11.0 lbs of a feed ingredient(s) or a portion of the non-medicated feed. Then add 0.8 to 50 lbs of intermediate premix per ton of finished feed.

VETERINARY INDICATIONS

Species	Grams bacitracin; per ton of feed	Indications for Use
Growing/finishing swine	10 - 30	For increased rate of weight gain and improved feed efficiency.
	250	For control of swine dysentery (bloody scours) associated with Brachyspira hyodysenteriae in pigs up to 250 lbs body weight. Feed 250 grams per ton of complete feed on premises with a history of swine dysentery, but where signs of the disease have not yet occurred or following an approved treatment of the disease condition.
		The 250 g/ton level will provide 5 to 7 mg/lb in swine weighing 40 to 250 lbs.
		CAUTION: Diagnosis should be confirmed by a veterinarian when results are not satisfactory. Feed containing an approved level of bacitracin methylene disalicylate should be the sole ration.
Pregnant sows	250	For control of clostridial enteritis caused by C. perfringens in suckling piglets when fed to sows from 14 days before through 21 days after farrowing on premises with a history of clostridial scours.
		CAUTION: Diagnosis should be confirmed by a veterinarian when results are not satisfactory. Feed containing an approved level of bacitracin methylene disalicylate should be the sole ration.
Broiler and replacement chickens	4 - 50	For increased rate of weight gain and improved feed efficiency.
	50	As an aid in prevention of necrotic enteritis caused or complicated by Clostridium spp. or other organisms susceptible to bacitracin methylene disalicylate.
	100 - 200	As an aid in control of necrotic enteritis caused or complicated by Clostridium spp. or other organisms susceptible to bacitracin methylene disalicylate.
		CAUTION: To control a necrotic enteritis outbreak, start medication at the first clinical signs of disease. The dosage range permitted provides for different levels based on severity of the infection. Consult a poultry diagnostic laboratory or pathologist to determine the diagnosis and advice regarding the optimal level of drug. Administer continuously for 5 - 7 days or as long as clinical signs persist, and then reduce medication to prevention level (50 g/ton).
Laying hens	10 - 25	For increased egg production and improved feed efficiency during the first seven months of production.
Growing turkeys	4 - 50	For increased rate of weight gain and improved feed efficiency.
	200	As an aid in control of transmissible enteritis in growing turkeys complicated by organisms susceptible to bacitracin methylene disalicylate.
Pheasants	4 - 50	For increased rate of weight gain and improved feed efficiency.
Quail	5 - 20	For increased rate of weight gain and improved feed efficiency in quail not over 5 weeks of age.
Feedlot beef cattle	mg/head/day
	70; (continuously)	For reduction in the number of liver condemnations due to abscesses in feedlot beef cattle.
	250; (5 days in 30)	For reduction in the number of liver condemnations due to abscesses in feedlot beef cattle.

SPL UNCLASSIFIED SECTION

Note: Where minimum levels are shown, increase the antibiotic concentration within approved range when necessary to fit the feeding program, and to ensure adequate levels of antibiotic in the complete ration.

Restricted Drug (California) - Use only as directed.

Not for human use.

For Use in Dry Feeds Only.

Not for Use in Liquid Medicated Feeds.

Store below 25°C (77°F), excursions permitted to 37°C (99°F).

NADA 46-592, Approved by FDA

SPL UNCLASSIFIED SECTION

Distributed by:

Zoetis Inc.

Kalamazoo, MI 49007

Net wt 50 LB (22.68 kg)

PRINCIPAL DISPLAY PANEL - 22.68 kg Bag Label

MD®
60

Bacitracin Methylene Disalicylate
Type A Medicated Article
Antibacterial

Net wt 50 LB (22.68 kg)

 Zoetis

BMD®
60

  

 

BMD 60 Label Bag

INGREDIENTS AND APPEARANCE

BMD  60
bacitracin methylene disalicylate granule

Product Information
Product Type	OTC TYPE A MEDICATED ARTICLE ANIMAL DRUG	Item Code (Source)	NDC: 54771-1602
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BACITRACIN METHYLENEDISALICYLATE (UNII: JGV6OJ52FT) (BACITRACIN - UNII:58H6RWO52I)	BACITRACIN METHYLENEDISALICYLATE	60 g  in 0.45 kg

Inactive Ingredients
Ingredient Name	Strength
CALCIUM CARBONATE (UNII: H0G9379FGK)

Product Characteristics
Color	GRAY (Gray to Brown)	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 54771-1602-1	22.68 kg in 1 BAG

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
NADA	NADA046592	01/01/2009

Labeler - Zoetis Inc. (828851555)

Establishment
Name	Address	ID/FEI	Business Operations
Zoetis LLC		099219842	API MANUFACTURE, MANUFACTURE